{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T22:38:26Z","timestamp":1767220706605,"version":"3.48.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,31]]},"DOI":"10.7759\/cureus.100520","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T22:34:43Z","timestamp":1767220483000},"source":"Crossref","is-referenced-by-count":0,"title":["Diagnosis of Prostate Cancer via Transanal Endoscopic Ultrasound\u2013Guided Fine-Needle Biopsy in a Patient With Bone Lesions and a Rapid Clinical Response to Enzalutamide Plus Degarelix"],"prefix":"10.7759","author":[{"given":"Akinori","family":"Sasaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Yamaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rika","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung H","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021, 71:209-49. 10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15051518","article-title":"Bone metastases and health in prostate cancer: from pathophysiology to clinical implications","volume":"15","author":"Baldessari C","year":"2023","unstructured":"Baldessari C, Pipitone S, Molinaro E, et al.. Bone metastases and health in prostate cancer: from pathophysiology to clinical implications. Cancers (Basel). 2023, 15:1518. 10.3390\/cancers15051518","journal-title":"Cancers (Basel)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2022.100518","article-title":"Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with prostate cancer","volume":"7","author":"Kanesvaran R","year":"2022","unstructured":"Kanesvaran R, Castro E, Wong A, et al.. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with prostate cancer. ESMO Open. 2022, 7:100518. 10.1016\/j.esmoop.2022.100518","journal-title":"ESMO Open"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1303917","article-title":"Cancer of unknown primary site","volume":"371","author":"Varadhachary GR","year":"2014","unstructured":"Varadhachary GR, Raber MN. Cancer of unknown primary site. N Engl J Med. 2014, 371:757-65. 10.1056\/NEJMra1303917","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/s1091-255x(01)00012-9","article-title":"Endoscopic ultrasound-guided transrectal biopsies of pelvic tumors","volume":"6","author":"Sailer M","year":"2002","unstructured":"Sailer M, Bussen D, Fein M, Freys S, Debus SE, Thiede A, Fuchs KH. Endoscopic ultrasound-guided transrectal biopsies of pelvic tumors. J Gastrointest Surg. 2002, 6:342-6. 10.1016\/s1091-255x(01)00012-9","journal-title":"J Gastrointest Surg"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-020-01582-8","article-title":"Endoscopic ultrasound-guided fine-needle aspiration of pelvic lesions via the upper and lower gastrointestinal tract approaches","volume":"21","author":"Mita N","year":"2021","unstructured":"Mita N, Iwashita T, Senju A, et al.. Endoscopic ultrasound-guided fine-needle aspiration of pelvic lesions via the upper and lower gastrointestinal tract approaches. BMC Gastroenterol. 2021, 21:18. 10.1186\/s12876-020-01582-8","journal-title":"BMC Gastroenterol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.02335.x","article-title":"Solitary pelvic nodule: diagnosis of metastatic prostate cancer by endoscopic ultrasound-guided, fine-needle aspiration","volume":"95","author":"Woodward TA","year":"2000","unstructured":"Woodward TA, Menke DM, Buskirk SJ. Solitary pelvic nodule: diagnosis of metastatic prostate cancer by endoscopic ultrasound-guided, fine-needle aspiration. Am J Gastroenterol. 2000, 95:2372-3. 10.1111\/j.1572-0241.2000.02335.x","journal-title":"Am J Gastroenterol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1903835","article-title":"Enzalutamide with standard first-line therapy in metastatic prostate cancer","volume":"381","author":"Davis ID","year":"2019","unstructured":"Davis ID, Martin AJ, Stockler MR, et al.. Enzalutamide with standard first-line therapy in metastatic prostate cancer. N Engl J Med. 2019, 381:121-31. 10.1056\/NEJMoa1903835","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.00799","article-title":"ARCHES: a randomized, phase III study of androgen deprivation therapy with enzalutamide or placebo in men with metastatic hormone-sensitive prostate cancer","volume":"37","author":"Armstrong AJ","year":"2019","unstructured":"Armstrong AJ, Szmulewitz RZ, Petrylak DP, et al.. ARCHES: a randomized, phase III study of androgen deprivation therapy with enzalutamide or placebo in men with metastatic hormone-sensitive prostate cancer. J Clin Oncol. 2019, 37:2974-86. 10.1200\/JCO.19.00799","journal-title":"J Clin Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1704174","article-title":"Abiraterone plus prednisone in metastatic, castration-sensitive prostate cancer","volume":"377","author":"Fizazi K","year":"2017","unstructured":"Fizazi K, Tran N, Fein L, et al.. Abiraterone plus prednisone in metastatic, castration-sensitive prostate cancer. N Engl J Med. 2017, 377:352-60. 10.1056\/NEJMoa1704174","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2119115","article-title":"Darolutamide and survival in metastatic, hormone-sensitive prostate cancer","volume":"386","author":"Smith MR","year":"2022","unstructured":"Smith MR, Hussain M, Saad F, et al.. Darolutamide and survival in metastatic, hormone-sensitive prostate cancer. N Engl J Med. 2022, 386:1132-42. 10.1056\/NEJMoa2119115","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2022.0063","article-title":"NCCN Guidelines\u00ae insights: prostate cancer, version 1.2023","volume":"20","author":"Schaeffer EM","year":"2022","unstructured":"Schaeffer EM, Srinivas S, Adra N, et al.. NCCN Guidelines\u00ae insights: prostate cancer, version 1.2023. J Natl Compr Canc Netw. 2022, 20:1288-98. 10.6004\/jnccn.2022.0063","journal-title":"J Natl Compr Canc Netw"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70303-1","article-title":"Effect of enzalutamide on time to first skeletal-related event, pain, and quality of life in men with castration-resistant prostate cancer: results from the randomised, phase 3 AFFIRM trial","volume":"15","author":"Fizazi K","year":"2014","unstructured":"Fizazi K, Scher HI, Miller K, et al.. Effect of enzalutamide on time to first skeletal-related event, pain, and quality of life in men with castration-resistant prostate cancer: results from the randomised, phase 3 AFFIRM trial. Lancet Oncol. 2014, 15:1147-56. 10.1016\/S1470-2045(14)70303-1","journal-title":"Lancet Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.21756","article-title":"Endoscopic ultrasound-guided FNA of pelvic lesions: a large single-center experience","volume":"124","author":"Hassan GM","year":"2016","unstructured":"Hassan GM, Paquin SC, Albadine R, Gari\u00e9py G, Soucy G, Nguyen BN, Sahai AV. Endoscopic ultrasound-guided FNA of pelvic lesions: a large single-center experience. Cancer Cytopathol. 2016, 124:836-41. 10.1002\/cncy.21756","journal-title":"Cancer Cytopathol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1207506","article-title":"Increased survival with enzalutamide in prostate cancer after chemotherapy","volume":"367","author":"Scher HI","year":"2012","unstructured":"Scher HI, Fizazi K, Saad F, et al.. Increased survival with enzalutamide in prostate cancer after chemotherapy. N Engl J Med. 2012, 367:1187-97. 10.1056\/NEJMoa1207506","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1405095","article-title":"Enzalutamide in metastatic prostate cancer before chemotherapy","volume":"371","author":"Beer TM","year":"2014","unstructured":"Beer TM, Armstrong AJ, Rathkopf DE, et al.. Enzalutamide in metastatic prostate cancer before chemotherapy. N Engl J Med. 2014, 371:424-33. 10.1056\/NEJMoa1405095","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2020-000408","article-title":"Endoscopic ultrasound (EUS) and the management of pancreatic cancer","volume":"7","author":"Yousaf MN","year":"2020","unstructured":"Yousaf MN, Chaudhary FS, Ehsan A, et al.. Endoscopic ultrasound (EUS) and the management of pancreatic cancer. BMJ Open Gastroenterol. 2020, 7:e000408. 10.1136\/bmjgast-2020-000408","journal-title":"BMJ Open Gastroenterol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/gastro\/gou057","article-title":"Endoscopic ultrasound in the diagnosis of cholangiocarcinoma as the etiology of biliary strictures: a systematic review and meta-analysis","volume":"3","author":"Navaneethan U","year":"2015","unstructured":"Navaneethan U, Njei B, Venkatesh PG, Lourdusamy V, Sanaka MR. Endoscopic ultrasound in the diagnosis of cholangiocarcinoma as the etiology of biliary strictures: a systematic review and meta-analysis. Gastroenterol Rep (Oxf). 2015, 3:209-15. 10.1093\/gastro\/gou057","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1055\/a-1223-2171","article-title":"Comparison of endoscopic ultrasound-guided fine-needle biopsy versus fine-needle aspiration for genomic profiling and DNA yield in pancreatic cancer: a randomized crossover trial","volume":"53","author":"Kandel P","year":"2021","unstructured":"Kandel P, Nassar A, Gomez V, et al.. Comparison of endoscopic ultrasound-guided fine-needle biopsy versus fine-needle aspiration for genomic profiling and DNA yield in pancreatic cancer: a randomized crossover trial. Endoscopy. 2021, 53:376-82. 10.1055\/a-1223-2171","journal-title":"Endoscopy"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.32147","article-title":"Recurrent metastatic renal cell carcinoma diagnosed with endoscopic ultrasound-guided fine needle aspiration 18 years after initial surgery","volume":"14","author":"Ahmed S","year":"2022","unstructured":"Ahmed S, Garapati M, Eloubeidi MA. Recurrent metastatic renal cell carcinoma diagnosed with endoscopic ultrasound-guided fine needle aspiration 18 years after initial surgery. Cureus. 2022, 14:e32147. 10.7759\/cureus.32147","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/436852-diagnosis-of-prostate-cancer-via-transanal-endoscopic-ultrasound-guided-fine-needle-biopsy-in-a-patient-with-bone-lesions-and-a-rapid-clinical-response-to-enzalutamide-plus-degarelix","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T22:34:44Z","timestamp":1767220484000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/436852-diagnosis-of-prostate-cancer-via-transanal-endoscopic-ultrasound-guided-fine-needle-biopsy-in-a-patient-with-bone-lesions-and-a-rapid-clinical-response-to-enzalutamide-plus-degarelix"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,31]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.100520","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,31]]}}}